Literature DB >> 3838313

Human liver fatty acid binding protein. Isolation of a full length cDNA and comparative sequence analyses of orthologous and paralogous proteins.

J B Lowe, M S Boguski, D A Sweetser, N A Elshourbagy, J M Taylor, J I Gordon.   

Abstract

We have determined the primary structure of human liver fatty acid binding protein from an analysis of a full length cDNA. This 127-residue 14,178-Da protein exhibits a high degree of sequence conservation when compared to its orthologous homologue, rat liver fatty acid binding protein. It appears likely that this polypeptide arose from two intragenic duplication events. Using a variety of computational techniques, we were unable to find any evidence of amphipathic alpha helical domains in this protein nor any sequence similarities to apolipoproteins and serum albumins. A family of paralogous proteins was defined, whose members share a remarkable degree of sequence homology with share a remarkable degree of sequence homology with human liver fatty acid binding protein. These include rat intestinal fatty acid binding protein, the cellular the P2 protein of myelin. It appears that the small cytosolic fatty acid binding proteins have evolved structural features necessary for lipid-protein interaction which are different from those present in some familiar and better studied extracellular sequences.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Assessing self-renewal and differentiation in human embryonic stem cell lines.

Authors:  Jingli Cai; Jia Chen; Ying Liu; Takumi Miura; Yongquan Luo; Jeanne F Loring; William J Freed; Mahendra S Rao; Xianmin Zeng
Journal:  Stem Cells       Date:  2005-11-17       Impact factor: 6.277

2.  Cloning of the cDNA encoding human skeletal-muscle fatty-acid-binding protein, its peptide sequence and chromosomal localization.

Authors:  R A Peeters; J H Veerkamp; A Geurts van Kessel; T Kanda; T Ono
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization.

Authors:  R G Maatman; T H Van Kuppevelt; J H Veerkamp
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

Review 4.  Functions of fatty acid binding proteins.

Authors:  R M Kaikaus; N M Bass; R K Ockner
Journal:  Experientia       Date:  1990-06-15

5.  The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Authors:  Gregory G Martin; Avery L McIntosh; Huan Huang; Shipra Gupta; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

6.  Expression of rat L-FABP in mouse fibroblasts: role in fat absorption.

Authors:  F Schroeder; J R Jefferson; D Powell; S Incerpi; J K Woodford; S M Colles; S Myers-Payne; T Emge; T Hubbell; D Moncecchi
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

7.  Research of an in vitro model to study the expression of fatty acid-binding proteins in the small intestine.

Authors:  A Mallordy; P Besnard; H Carlier
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

8.  Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro.

Authors:  G Siegenthaler; R Hotz; D Chatellard-Gruaz; L Didierjean; U Hellman; J H Saurat
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

Review 9.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

10.  Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction.

Authors:  R G Maatman; E M van de Westerlo; T H van Kuppevelt; J H Veerkamp
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.